36 results
8-K
AGIO
Agios Pharmaceuticals Inc
16 Dec 22
Departure of Directors or Certain Officers
4:02pm
of Certain Officers; Compensatory Arrangements of Certain Officers.
Performance-Based Cash Bonus Plan
On December 12, 2022, the Compensation … and People Committee of the Board of Directors of Agios Pharmaceuticals, Inc. (the “Company”) adopted a performance-based cash bonus plan, pursuant to which
8-K
AGIO
Agios Pharmaceuticals Inc
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
, Ms. Milanova will be eligible to receive a discretionary annual performance and retention bonus with a target of 45% of her then annual base salary … . Milanova will receive a sign-on bonus of $150,000 in connection with the commencement of her employment with the Company. Ms. Milanova
8-K
EX-10.1
rui96 d7gfmf2z
7 Oct 22
Departure of Directors or Certain Officers
4:05pm
8-K
fozs 6845zdo1cbeq
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
2vjp8pq
12 Jul 22
Agios Appoints Brian Goff as Chief Executive Officer
4:14pm
8-K
a7v9l6ekl121 uioesu
29 Jul 21
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
7:17am
DEFM14A
ar20i75b
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
1m5oz6y8124qzk15ku9o
29 Jan 21
Preliminary proxy related to merger
4:22pm
DEFA14A
q7mz3wn7zr7n8fhk7v
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
EX-2.1
q7mwm9fm 53v
21 Dec 20
Additional proxy soliciting materials
9:17pm
8-K
EX-2.1
gjj6pjwmvc4
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
S-3ASR
EX-1.2
vhxbr2xu0v241
30 Apr 20
Automatic shelf registration
4:19pm